Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Novartis' Multiple Sclerosis Drug Gilenia Poised for Approval
Novartis' Multiple Sclerosis Drug Gilenia Poised for Approval
Novartis' Multiple Sclerosis Drug Gilenia Poised for Approval
Submitted by
admin
on September 21, 2010 - 9:19am
Source:
Minyanville
News Tags:
Novartis
Gilenia
FDA
MS
multiple sclerosis
Headline:
Novartis' Multiple Sclerosis Drug Gilenia Poised for Approval
Do Not Allow Advertisers to Use My Personal information
